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ABSTRACT
Malaria infection during pregnancy is a significant global health problem with substantial 
risks for pregnant women, her foetus, and the newborn child. Infant malaria is a major 
public health concern in Timika, Papua. The aim of the study was to investigate the impact 
of malaria during pregnancy on infant’s susceptibility to malaria infections, the timing of 
its occurrence, the number of malaria infections during pregnancy. This was a cohort 
prospective study conducted in Timika, Papua from October 2013 to September 2016. 
Malaria investigation was done by microscopic and PCR methods. Demographic data and 
malaria status of mother-infant pairs were collected and analyzed by SPSS 22.0 version. 
One hundred seventy-eight infants consisting of 95 (53.37%) infants born to mothers 
with malaria and 83 (46.63%) without malaria 91 (51.12%) boys and 87 (48.88%) girls 
were involved in the study. The mean of mothers’ ages were 25.35 ± 6.30 vs. 26.0 ± 
5.69 years. At the ages of 6 and 12 months, infants born to malaria positive mothers 
were more susceptible to malaria infections compared to infants born to malaria negative 
mothers with RR = 3.49; 95%CI: 1.02-11.96; p = 0.03 and RR = 8.74; 95%CI: 1.14-
66.81; p = 0.01, respectively. Independent risk factors of infant susceptibility to malaria 
infection during the first year of life were malaria in pregnancy (MiP) in 2nd trimester (RR 
= 4.50; 95%CI: 1.5-13.49; p = 0.07), pregnant women who only got malaria infection 
1 time during pregnancy (RR=2.95; 95%CI: 1.04-8.33; p = 0.04), and Papuan ethnicity 
(RR=3.58; 95%CI: 1.22-10.59; p = 0.02). In conclusion, infant susceptibility to malaria 
is associated with maternal malaria status during pregnancy. MiP in second trimester, 
pregnant women who only had malaria once and Papuan ethnicity were independent risk 
factors for infant’s increased susceptibility to malaria infection.
ABSTRAK
Infeksi malaria selama kehamilan merupakan masalah kesehatan global yang signifikan 
dengan risiko besar bagi ibu hamil, janin, dan bayi yang dilahirkan. Malaria pada bayi 
merupakan masalah kesehatan masyarakat utama di Timika, Papua. Penelitian ini bertujuan 
untuk mengkaji dampak malaria selama kehamilan terhadap kerentanan bayi pada infeksi 
malaria, waktu terjadinya infeksi malaria pada ibu, jumlah infeksi malaria selama kehamilan. 
Penelitian ini merupakan penelitian kohort prospektif yang dilakukan di Timika, Papua dari 
bulan Oktober 2013 sampai September 2016. Pemeriksaan malaria pada wanita hamil 
dan bayi dilakukan dengan metode mikroskopik dan PCR. Data demografi dan status 
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malaria pasangan ibu-bayi dikumpulkan dan dianalisis dengan SPSS versi 22.0. Sebanyak 
178 bayi yang terdiri dari 95 (53,37%) bayi yang lahir dari ibu dengan malaria dan 83 
(46,63%) tanpa malaria dan 91 (51,12%) bayi laki-laki dan 87 (48,88%) bayi perempuan 
dilibatkan dalam penelitian. Rata-rata usia ibu adalah 25,35 ± 6,30 vs 26,0 ± 5,69 tahun. 
Pada usia 6 dan 12 bulan, bayi yang lahir dari ibu positif malaria lebih rentan terhadap 
infeksi malaria dibandingkan dengan bayi dari ibu negatif malaria (RR = 3,49; IK 95%: 
1,02-11,96; p = 0,03 dan RR = 8,74; IK 95%: 1,14-66,81; p = 0,01). Faktor risiko 
independen pada kerentanan bayi terhadap infeksi malaria selama tahun pertama adalah 
malaria pada kehamilan saat trimester kedua (RR = 4,50; IK 95%: 1,5-13,49; p = 
0,07), wanita hamil yang hanya terinfeksi malaria 1 kali selama kehamilan (RR = 2,95; 
IK 95%: 1,04-8,33; p = 0,04), dan etnis Papua (RR = 3,58; IK 95%: 1,22-10,59; p = 
0,02). Dapat disimpulkan, kerentanan bayi terhadap malaria berhubungan dengan status 
malaria ibu selama kehamilan. Malaria pada kehamilan trimester kedua, wanita hamil 
yang hanya terinfeksi malaria satu kali selama kehamilan dan etnis Papua adalah faktor 
risiko independen terkait peningkatan kerentanan bayi terhadap infeksi malaria.
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INTRODUCTION
Malaria is a mosquito-borne infectious 
disease caused by the parasite Plasmodium. 
The predominant species are Plasmodium 
falciparum and P. vivax with an estimated 
182.2 million clinical cases of P. falciparum 
malaria, 15.8 million clinical cases of P. vivax 
malaria and 584,000 deaths attributable to 
malaria every year.1 The greatest burden of 
disease is reported in young children and 
pregnant women.2 Annually, 88.2 (70%) of 
125.2 million pregnancies in malaria endemic 
regions occur in the Asia-Pacific area.3 
Malaria in pregnancy (MiP) or pregancy-
associated malaria, is defined as peripheral 
or placental infection by Plasmodium. The 
MiP presents as a major public health concern 
due to significant adverse health effects on 
both the mother and the fetus.4 The effects of 
MiP on infants include intra-uterine growth 
retardation (IUGR) and pre-term delivery, low 
birth weight (LBW), abortion and stillbirth, 
congenital malaria and foetal anaemia.5 
The risk of IUGR associated with malaria 
was greatest after three or more cumulative 
infections (RR 3.3; 95%CI: 1.3–8.2) and was 
two to eight-fold higher among women with 
evidence of undernutrition.6 Submicroscopic 
malaria infections in pregnant women were 
associated with significantly increased risks 
of low birth weight in primigravidae and 
premature births in multigravidae.7 
According to Poespoprojo8 infant malaria 
is a major public health issue in Timika, Papua 
(Indonesia) and the risk starts at birth with the 
majority of malaria cases going undiagnosed, 
being mostly asymptomatic. Newborns and 
young infants (less than 6 months of age) 
are thought to be relatively protected from 
symptomatic malaria.9 This protection has been 
considered to be primarily mediated by maternal 
antimalarial IgG antibodies transferred to the 
foetus in the last trimester of pregnancy.10 
Antimalarial IgG antibodies may have 
three roles: first blocking sporozoite invasion 
of hepatocytes and merozoite invasion of 
erythrocytes; second, opsonize merozoites 
and infected erythrocytes expressing variant 
surface antigens (VSA) on their surface for 
phagocytosis; and third, fixing and activating 
complements on the merozoite surface with 
resultant parasite lysis.11 Primarily in the third 
trimester, transplacental transfer of maternal 
IgG antibodies to the foetus occurs and is 
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mediated by the neonatal Fc receptor.12 After 
birth, all isotypes of maternal antibodies, except 
for IgA, are transferred to infants in breast milk, 
despite the fact that these are not systemically 
absorbed and act primarily in the gut.13 The 
waning of maternal antimalarial IgG antibodies 
by 6–9 months of age had been reported 
previously, which coincides with the period of 
time in which the risk for malaria infection and 
clinical disease in infants begins to increase.14
Beside transplacental transfer of protective 
antibodies from mother to foetus, several factors 
that allegedly contribute to the susceptibility 
of infants to malaria are innate mechanisms 
including haemoglobin foetus (HbF),15 para 
amino benzoic acid (PABA)-deficiency and 
transforming growth factor (TGF) in breast 
milk, exclusive breast feeding,16 neonatal 
responses to priming by transplacental transfer 
of parasites or products,17 placental malaria,18 
infant nutritional status, high exposure to 
Plasmodium,19 and proper implementation 
of insecticide-treated nets and intermittent 
preventive treatment.20 
In placental intervillous spaces the 
parasite specific adhesion may contribute 
to placental insufficiency which may relate, 
either directly or indirectly, to foetal growth 
restriction and premature birth. Susceptibility 
of women to placental malaria is attributed 
to increased parasites sequestered in the 
placenta mediated by chondroitin sulfate A 
binding to the trophoblast21 and pregnancy-
associated suppression of inflammatory 
responses caused by hormonal changes.22 
Pregnant women experience immunological 
and hormonal changes, particularly oestrogen 
and progesterone which are partly driven by 
increased levels of pregnancy-associated 
hormones.23 A recent study found the role of 
soluble human leukocyte antigen G (sHLA-G) 
in infant susceptibility to malaria during 
pregnancy.24 
There were some evidences of the effect 
of placental malaria on infants, which also 
includes greater susceptibility to malaria 
and anaemia in those born to mothers with 
a parasitized placenta.17, 25 All these studies 
have focused on placental infection at 
delivery, with no exploration of the mother’s 
history of infection earlier during pregnancy. 
Our study aimed to investigate the impact 
of MiP on infant susceptibility to malaria 
infection, taking into account the timing of its 
occurrence, the number of MiP infections and 
demographic data during the first year of life. 
MATERIALS AND METHODS
Subjects
The study was conducted from October 
2013 to September 2016 in lowland Timika, 
Papua Indonesia, an area where P. falciparum 
and P. vivax malaria are similarly prevalent. This 
was a nested study from a cluster randomized 
trial of maternal malaria prevention and 
treatment. Pregnant women with gestational 
age < 24 weeks were enrolled at their first 
antenatal visit at Posyandu (community health 
centre) after giving written informed consent. 
The subjects of this study were the infants 
born to these mothers who were enrolled 
consecutively until the number of sample size 
was sufficient. Inclusion criteria were healthy 
term newborns and consenting mothers living 
in the study areas for the duration of follow-
up. The babies would be excluded if preterm 
(< 37 weeks gestation), sick newborns 
requiring hospitalization, withdrawal by the 
parent/mother, and loss to follow-up for more 
than 6 months. 
Sample size of infants was based on the 
cohort prospective method26 with RR = 2.13 
assumed as significant, where the prevalence 
of malaria in infants in group without risk 
factor was (P2) = 0.12327 with α= 0.05; power 
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80%; zα=1.96; and zβ= 0.842, then the project 
required a sample size of 162 infants (81 per 
arm). Ethics approval was obtained from the 
Medical and Health Research Ethics Committee 
at the Faculty of Medicine, Universitas Gadjah 
Mada, Yogyakarta, Indonesia. 
Protocol
Pregnant women were followed-up 3 or 4 
times (3 if enrolled after 24 weeks and 4 times 
if enrolled between 16-23 weeks) and again 
at delivery. At those times blood samples 
were taken from the finger prick for malaria 
investigation. Infants born to a mother with 
either MiP or no MiP would be followed for 
1 year and we performed malaria laboratory 
diagnosis at 6 and 12 months. 
The diagnosis of malaria both in mothers 
and infants were based on PCR examination. 
Demographic data from the mother included: 
age, gravidity, ethnicity and bed net utilization 
while from the baby data included: gender, birth 
weight, birth length and head circumference. 
Gestational age at birth were assessed from 
neuromuscular and physical maturity score 
of the newborn according to Ballard methods. 
The procedures were performed by a trained 
research nurse. 
Statistical analysis
Statistical analysis using SPSS version 
22.0 (UGM online license). Numerical data 
with normal distribution were analyzed 
using student t test or one way analysis of 
variance (Anova). If there was an abnormal 
distribution then it would be analyzed using 
Mann-Whitney U test. Categorical data were 
analyzed using chi square test with Yates 
correction or Fisher exact test. Statistical 
significance was considered if p <0.05. To 
control confounding variables and look for 
independent risk factors from malaria in 
infants, bivariate and multivariate tests were 
be performed.
RESULTS
One hundred and ninety three mother–
infant pairs were enrolled between October 
2013 and September 2016. There were 4 
parental refusals. Among 193 infants, 9 
infants did not complete the 12 months follow 
up (4 infants from mother without MiP and 5 
infants from mother with MiP), and 2 infants 
died from mothers with MiP due to sepsis and 
watery diarrhoea (FIGURE 1).
193 pregnant woman and infant pairs
4 parents refusal
189 infants
followed up for 12 months
87
infants born to
mother without MiP
102
infants born to mother
with MiP 128
4 lost to follow up
95 infants
-5 lost to follow up
-2 death (1 sepsis, 1 severe
dehydration caused by diarrhoea)
83 infants
analysis analysis FIGURE 1. Flowchart of subject selection. 
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During the pregnancy, 46 women were 
infected during the 1st trimester, 54 during the 
2nd trimester, and 14 during the 3rd trimester. 
There were 48 (27%) pregnant women that 
had at least one malaria infection, 29 (16.3%) 
had two infections, 14 (7.98%) had 3 or more 
infections and 87 (48.9%) had no infection. 
During delivery there were 44 mothers who 
had malaria infection, where 42 mothers had 
positive placental infection and 22 mothers had 
peripheral parasitemia. The mean of mother age 
was 25.35 ± 6.30 vs 26.0 ± 5.69 years, and the 
youngest was 12 years old and the oldest was 42 
years old (TABLE 1). There were no significant 
differences in baseline characteristics between 
mothers with MiP and without MiP. 
TABLE 1. Mother baseline characteristics
Characteristic Malaria in pregnancy (+) n = 95
Malaria in pregnancy (-) 
n = 83 p*
Age (years ± SD) 25.35 ± 6.30 26.0 ± 5.69 0.14
Gravidity, n (%) 
• Primigravidae 
• Secundigravidae 
• Multigravidae
31 (17.4) 
25 (14.0) 
39 (21.9)
17 (9.6) 
34 (19.2) 
32 (17.9)
0.69
Ethnic Group, n (%) 
• Papuan 
• Non Papuan
48 (27.0) 
47 (26.4)
38 (21.3) 
45 (25.3) 0.53
Bed net utilization 
• Yes 
• No
28 (15.7) 
67 (37.6)
24 (13.5) 
59 (33.2) 0.94
*Fisher exact test, significant if p <0.05
TABLE 2 shows that there were 91 
(51.12%) boys and 87 (48.88%) girls. Birth 
weight, head circumference and low birth 
weight were more likely to occur in infants 
from mothers with MiP positive compared 
with MiP negative mothers, but these results 
were not significant (p>0.05).
TABLE 2. Characteristics of infant
Characteristics Malaria in Pregnancy (+) n = 95
Malaria in Pregnancy (-) 
n = 83 p*
Gender, n (%) 
• Boy 
• Girl
50 (28.1) 
45 (25.3)
41 (23.0) 
42 (23.6) 0.67
Birth weight (mean ± SD) 3028.95 ± 450.87 3051.21 ± 388.13 0.32
Birth length (mean ± SD) 49.13 ± 2.08 49.02 ± 2.06 0.68
Head circumference (mean±SD) 32.73 ± 1.56 33.02 ± 1.62 0.54
Gestational age (mean ± SD) 37.76 ± 1.07 37.53 ± 0.89 0.45
Low birth weight, n (%) 
• Yes 
• No
11 (6.2) 
84 (47.2)
3 (1.7) 
80 (44.9) 0.55
*Fisher exact test, significant if p < 0.05
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TABLE 3 shows a bivariate analysis of 
the effects of MiP on infant malaria infections 
at age 6 and 12 months in which infants born 
to mother with MiP were more susceptible to 
malaria infection than infants born to mother 
without MiP (p = 0.03; RR = 3.49; 95% CI 
1.02-11.96) and (p = 0.01; RR = 8.74; 95% CI 
1.14-66.81) respectively.
TABLE 3. Malaria infant in 6 and 12 months old
Variable 
Malaria Infant, n (%)
p* RR 95% CI
(+) (-)
6 months old
MiP (+) 12 (12.63) 83 (87.37)
0.03 3.49 1.02-11.96
MiP (-) 3 (3.61) 80 (96.39)
12 months old MiP (+) MiP (-)
10 (10.53) 
1 (1.21)
85 (89.47) 
82 (98.79) 0.01 8.74 1.14-66.81
*Fisher exact test, significant if p < 0.05
We performed a multivariate analysis 
between all malaria infections over a period of 
12 months with malaria-infected timings and 
maternal demographics (TABLE 4). In this 
study we found that MiP which occurred in 
second trimester, pregnant women who only 
had malaria infection 1 time before delivery 
and Papuan ethnicity were independent 
factors related to the infant susceptibility to 
malaria infection.
TABLE 4. Factors related to susceptibility infant to malaria infection at 6 and 12 months old
Characteristics
Infant Parasitemia Crude Logistic Regression
(+) (-) RR 95%CI p RR 95%CI p
Malaria during pregnancy
 1st Trimester  
• Yes 
• No
2 (20.0) 
19 (11.3)
8 (80.0) 
149 (88.7) 1.77 0.48-6.55 0.41 2.76 0.41-18.43 0.29
2ndTrimester 
• Yes 
• No
12 (25.0) 
9 (6.9)
36 (75.0) 
121 (93.1) 3.61 1.63-8.02 0.00 4.21 1.36-13.60 0.01
3rdTrimester 
• Yes 
• No
5 (13.5) 
16 (11.3)
32 (86.5) 
125 (88.7) 1.19 0.47-3.04 0.72 0.99 0.27-3.74 0.99
Malaria infection 1 time 
• Yes 
• No
9 (18.8) 
12 (9.2)
39 (81.2) 
118 (90.8) 2.03 0.91-4.51 0.81 3.39 1.09-10.57 0.03
Parasitemia at Delivery
Peripheral 
• Yes 
• No
4 (16.7) 
17 (11.0)
20 (83.3) 
137 (89.0) 1.51 0.56-4.11 0.43 2.43 0.18-33.64 0.51
Placental 
• Yes 
• No
6 (14.6) 
15 (10.9)
35 (85.4) 
122 (89.1) 1.34 0.55-3.22 0.51 2.99 0.41-22.12 0.28
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Primigravidae 
• Yes 
• No
6 (12.5) 
15 (11.5)
42 (87.5) 
115 (88.5) 1.08 0.45-2.63 0.86 1.63 0.47-5.69 0.44
Mother Age 
• <18 years 
• >18 years
2 (11.1) 
19 (11.9)
16 (88.9) 
141 (88.1) 0.94 0.24-3.19 0.48 0.53 0.09-3.09 0.48
Ethnicity 
• Papuan 
• Non Papuan
15 (17.4) 
6 (6.5)
71 (82.6) 
86 (93.5) 2.67 1.09-6.58 0.03 3.35 1.09-10.28 0.03
Bednet Utilization 
• Yes 
• No
8 (14.4) 
13 (10.3)
44 (84.6) 
113 (89.7) 1.49 0.66-3.38 0.34 2.53 0.78-8.19 0.12
DISCUSSION
We found that at 6 and 12 months old, MiP 
was related to malaria infection in infants. This 
study is consistent with previous studies that 
found a significant relationship between MiP 
and infant susceptibility to malaria infection27 
and it also correlated with the increasing of 
malaria episodes during infancy.28 Infants born 
to positive MiP mothers are more susceptible 
to malaria, presumably because placental 
malaria causes the transfer of maternal 
antibody decrease29 leading to increase of 
infant susceptibility to malaria infection. 
Our study found that after logistic 
regression analysis, MiP occurrence in the 
second trimester was independently associated 
with infant susceptibility to malaria infection 
in the first year of life (RR = 4.21; 95% CI 1.36-
13.60; p=0.01) (TABLE 4). This finding is in 
contrast with the result of a previous study18 
that found MiP in the third trimester increased 
the risk of malaria infection during the first 
year of life. The association between MiP in 
the second trimester and infant susceptibility 
to malaria infection was thought to be related 
to the duration of malaria exposures in the 
mother.22 Malhotra et al.17 reported a tolerant 
immune process that occurred depending 
on the type of malaria antigen in contact 
with the foetus, the number of parasites and 
the duration of exposure and timing during 
pregnancy. This finding supports the premise 
that although the mother was exposed to 
malaria but the foetus has not been sensitized, 
so the infants are more susceptible to malaria 
infection.17 Boudova et al.18 reported that 
only placental infection during pregnancy is 
associated with increased risk of malaria in 
infancy, but in this study we found there was 
no significant correlation between placental 
malaria and infant susceptibility to malaria.
Another study reported that primigravidae 
are at greater risk of MiP compared to 
multigravidae30 and their offspring are also 
more susceptible to malaria infection mainly 
as a result of reduced antibody transfer.31 
Yet in this study we did not find support for 
this conclusion. However, this study found 
that pregnant women who suffered from 
malaria as much as 1 time before delivery 
were associated with infant susceptibility to 
malaria infection. Among 26 cases of malaria 
in infants at 6 and 12 months of age, there 
were 4 infants who had malaria twice. The 
remaining of 21 cases consisted of 5 infants 
born to mothers without MiP, 7 infants born 
to mothers with MiP who had a different 
plasmodium species as their mothers and 
9 infants born to mothers with MiP had the 
same plasmodium species as their mothers. 
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In all of the 9 infants who have the same 
species as their mothers, malaria infection of 
the mother occurred 1 time during the second 
trimester. This phenomenon corresponds to 
the theory that naturally acquired immunity 
develops over time after repeated infections10 
and the development of antimalarial 
antibodies as well as maternal antimalarial 
antibodies transferred to the foetus in the last 
trimester are thought to play a crucial role.28 
In malaria endemic areas like in Timika 
Papua, individuals develop naturally acquired 
immunity to both P. falciparum and P. vivax 
after repeated infections.2 This immunity does 
not generally protect against infection per se, 
but protects against the development of high 
parasite densities and clinical symptoms.32 
HLA-G might play an important role in infant 
susceptibility to infection. A high level of 
soluble HLA-G (sHLA-G), a non-classical 
HLA class Ib antigen, with important immune-
regulatory functions33 was significantly 
associated with a higher incidence ratio of 
malaria in children.34 It was consistent with the 
fact that the inhibition of immune responses 
by HLA-G expression could lead to a greater 
susceptibility to malaria.24 In this study infant 
susceptibility to malaria infection besides 
being associated to MiP was also significantly 
correlated to Papuan ethnic (RR=3.35; 95%CI 
1.09-10.28; p=0.03) (TABLE 4). This finding 
is consistent with previous research that found 
an association between Papuan ethnicity and 
the risk of parasitemia in pregnant women.8
Although a complete explanation 
of the pathophysiology of MiP has not 
yet been developed, exposure to malaria 
intrauterine probably correlates with placental 
sequestration of erythrocytes. The immune 
tolerance process then depends on the 
type of malaria antigen in contact with the 
foetus, the amount and the duration of the 
exposure, and the timing of exposure during 
pregnancy. The timing of malaria episodes 
during pregnancy results in different effects 
on both the mother and the foetus, where 
parasitaemia appears to be higher during the 
first and second trimesters, although follow-
up on P. falciparum parasitaemia during the 
first trimester has seldom been complete.35
CONCLUSIONS
Infant susceptibility to malaria is 
associated with maternal malaria status during 
pregnancy. MiP in the second trimester, 
pregnant women who only had malaria once 
and Papuan ethnicity are independent risk 
factors for infant’s increased susceptibility to 
malaria infection.
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